An International Publisher for Academic and Scientific Journals
Author Login
Scholars Academic Journal of Pharmacy | Volume-4 | Issue-09
Analytical method development and validation of diloxanide furoate and ornidazole in its combined pharmaceutical dosage form
Hemangi Vaidya, Sweetu Patel, Divya Patel, Prasanna K Pradhan, Umesh Upadhyay
Published: Sept. 30, 2015 |
218
303
DOI: 10.36347/sajp
Pages: 398-404
Downloads
Abstract
A simple, rapid, economical, precise and accurate Stability indicating RP-HPLC method for simultaneous
estimation of Diloxanide Furoate and Ornidazole in Their Combined Dosage Form has been developed. The separation
was achieved by LC- 20 AT C18 (250mm x 4.6 mm x 2.6 μm) column and Buffer (pH 4.5): Acetonitrile (40:60) as
mobile phase, at a flow rate of 1 ml/min. Detection was carried out at 277 nm. Retention time of Ornidazole and
Diloxanide Furoate were found to be 4.620 min and 7.633 min, respectively. The method has been validated for linearity,
accuracy and precision. Linearity observed for Ornidazole 5-15 μg/ml and for Diloxanide Furoate 7.5-22.5 μg/ml. The
percentage recoveries obtained for Ornidazole and Diloxanide Furoate were found to be in range of 100.88 ± 0.60 and
100.85± 0.20 respectively. The proposed method was successfully applied for the simultaneous estimation of both the
drugs in commercial combined dosage form